Results for tag: "Arzerra"

Arzerra is a type of leukemia drug used to treat chronic lymphocytic leukemia (CLL). It is a monoclonal antibody that works by targeting a protein found on the surface of cancer cells. It is used in combination with other drugs to treat CLL that has not responded to other treatments. Arzerra is also used to treat a rare form of leukemia called Waldenström's macroglobulinemia. The Arzerra market is composed of pharmaceutical companies that manufacture and distribute the drug. These companies are involved in the research and development of new treatments for CLL and other forms of leukemia. They also provide support services to patients and healthcare professionals. Companies in the Arzerra market include Novartis, GlaxoSmithKline, Sanofi, and Roche. Show Less Read more